MASH中免疫细胞的代谢重编程
代谢功能障碍相关脂肪性肝病影响全球约30%成人,约六分之一患者进展为代谢功能障碍相关脂肪性肝炎(MASH),可演变为肝硬化和肝细胞癌。本文综述MASH中巨噬细胞和T细胞的代谢特征,并讨论靶向细胞代谢对上述细胞的影响及临床试验结果。
要点
- MASH中巨噬细胞表现为糖酵解增加、氧化磷酸化受损及脂质摄取、合成与脂肪酸氧化增强,促炎表型。
- T细胞和NK细胞等淋巴细胞代谢功能受损,削弱免疫监视能力并促进肝细胞癌发生。
- 靶向免疫细胞代谢是潜在治疗方向,但其他类型免疫细胞的代谢特征研究仍有限。
核心结论
- MASH中巨噬细胞和T细胞等免疫细胞发生代谢重编程,靶向细胞代谢可能影响这些细胞并成为治疗策略,但其他免疫细胞代谢特征研究仍有限,需进一步研究以阐明发病机制并开发新疗法。
研究设计与样本
- 综述,阐述MASH中免疫细胞(重点为巨噬细胞和T细胞)的代谢特征及靶向细胞代谢的临床试验结果,并提及单细胞基因组学和动物模型的发展。
主要发现
- MASH中巨噬细胞糖酵解增加、氧化磷酸化受损,脂质摄取、合成和脂肪酸氧化增强,共同促成其炎症表型。
- MASH中T细胞和NK细胞等淋巴细胞代谢功能受损,削弱免疫监视能力并促进肝细胞癌发生。
- 其他类型免疫细胞的代谢特征研究仍有限。
关键数值与推荐
- 代谢功能障碍相关脂肪性肝病影响全球约30%成人,约六分之一患者进展为MASH,并可演变为肝硬化和肝细胞癌。
临床怎么用
- 原文未据此给出推荐。
局限性
- 其他类型免疫细胞的代谢特征研究仍有限。
- 原文结论提及需进一步研究以阐明MASH发病机制并开发新治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metabolic dysfunction-associated steatotic liver disease, previously known as NAFLD, affects ~30% of adults worldwide. Approximately 1 out of 6 patients with metabolic dysfunction-associated steatotic liver disease progress to metabolic dysfunction-associated steatohepatitis (MASH) and potentially evolve toward cirrhosis and HCC. This condition imposes a significant burden on global health. Although MASH is primarily a metabolic disorder, immune cells play a crucial role in its development. The activation of immune cells involves alterations in transcription and protein synthesis, which require metabolic adaptation of cellular substrate metabolism, including glucose and lipid metabolism. Moreover, the lipid-rich environment of the liver can affect the metabolism of immune cells. In this review, we delineate the metabolic profiles of immune cells in MASH, focusing on macrophages and T cells, and discuss the impact of targeting cellular metabolism on these cells along with clinical trial outcomes. Macrophages in MASH are characterized by increased glycolysis, compromised oxidative phosphorylation, and augmented lipid uptake, synthesis, and fatty acid oxidation, all of which contribute to their inflammatory phenotype. Lymphocytes, such as T cells and NK cells, exhibit impaired metabolic functions that hamper their immune surveillance capabilities and facilitate the development of HCC. However, research on the metabolic characteristics of other types of immune cells remains limited. With the development of single-cell genomics and animal models of MASH, we anticipate that further studies in this compelling field may shed light on the pathogenesis of MASH and pave the way for novel therapeutic strategies.
引用
- Ma C, Wang S, Dong B, et al. Metabolic reprogramming of immune cells in MASH. Hepatology. 2025. PMID: 40324062. doi:10.1097/HEP.0000000000001371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。